+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rapid Diagnostics Market by Product Type, End User, Technology, Application - Global Forecast to 2030- Product Image
Rapid Diagnostics Market by Product Type, End User, Technology, Application - Global Forecast to 2030- Product Image
Sale

Rapid Diagnostics Market by Product Type, End User, Technology, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012257
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rapid diagnostics market is experiencing pivotal transformation, driven by evolving healthcare demands and accelerated by technical innovation. For healthcare executives, R&D leaders, and procurement professionals, understanding this landscape is essential for effective decision-making, risk management, and capturing emerging value creation opportunities.

Market Snapshot: Rapid Diagnostics Market Size and Growth

The rapid diagnostics market grew from USD 34.03 billion in 2024 to USD 38.26 billion in 2025. It is expected to continue expanding at a CAGR of 11.98%, projected to reach USD 67.14 billion by 2030. This growth reflects increasing adoption of decentralized testing models, technology integration across healthcare settings, and rising demand for timely medical decision support.

Scope & Segmentation

  • Product Types: Instruments including benchtop and portable devices; reagents and consumables for recurring use; test kits suitable for turnkey deployment across environments.
  • End Users: Hospitals with integrated workflows; laboratories with high-throughput systems; clinics focusing on patient satisfaction; home care providers supporting chronic disease management.
  • Technology Platforms: Immunoassay for quantitative biomarker analysis; lateral flow assays—both competitive and sandwich designs—for point-of-care and self-testing; molecular diagnostics featuring isothermal amplification and PCR systems for sensitive pathogen detection and genomic profiling.
  • Applications: Cardiac markers such as troponin, myoglobin, and creatine kinase MB; diabetes diagnostics encompassing both type 1 and type 2 monitoring; infectious disease diagnostics enabling bacterial, viral, and parasitic detection; oncology solutions targeting biomarker-driven screening and companion diagnostics.
  • Regional Coverage: Americas (notably major US states, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including leading EU states, Middle Eastern and African markets); Asia-Pacific (spanning China, India, Japan, Australia, South Korea, and Southeast Asia).
  • Key Companies: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., bioMérieux SA, Hologic Inc., DiaSorin S.p.A., Quidel Corporation.

Key Takeaways for Decision-Makers

  • Advances in molecular and immunoassay technologies are expanding the scope and capabilities of rapid diagnostics, supporting earlier intervention pathways across clinical specialties.
  • Digital integration, including real-time data transmission and AI-powered analytics, is optimizing diagnostic accuracy and facilitating streamlined clinical workflows in both urban and remote care settings.
  • Point-of-care testing is diversifying beyond traditional hospital and lab settings into ambulatory clinics, home environments, and field operations, creating new opportunities for product customization and deployment.
  • Regional nuances shape adoption—developed markets favor high-performance, integrated platforms, while emerging regions demand adaptable, cost-efficient diagnostic tools.
  • Strategic partnerships, supply chain resilience measures, and investment in R&D are central to staying competitive as reimbursement frameworks and regulatory demands evolve.

Tariff Impact on Rapid Diagnostics

Recent US tariff schedules have altered procurement strategies for diagnostic manufacturers and distributors. Elevated duties on imported components are increasing landed costs and prompting a shift toward tariff-exempt suppliers or reshoring of key production phases. Organizations are building supply chain resilience by expanding their supplier networks, creating regional assembly lines, and investing in inventory buffers. As a result, incremental price adjustments are emerging, with innovators adopting modular product designs to balance cost and performance.

Methodology & Data Sources

This report uses a robust methodology combining primary research through in-depth stakeholder interviews and secondary research from scientific publications, industry filings, and market associations. Data triangulation corrects discrepancies, while expert reviewers provide additional validation to ensure accuracy and actionable insight.

Why This Report Matters

  • Enables senior leaders to develop data-informed strategies for market entry, portfolio diversification, and operational resilience.
  • Provides clear, segmented intelligence on product, technology, regional, and application developments for effective opportunity assessment.
  • Supports compliance teams in navigating regulatory frameworks, reimbursement changes, and tariff considerations.

Conclusion

The rapid diagnostics market is poised for sustained advancement as stakeholders align innovation, regulatory strategy, and clinical value delivery. This analysis equips decision-makers to capture growth, mitigate risks, and lead in an evolving global healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rapid Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Benchtop
8.2.2. Portable
8.3. Reagents and Consumables
8.4. Test Kits
9. Rapid Diagnostics Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
9.5. Laboratories
10. Rapid Diagnostics Market, by Technology
10.1. Introduction
10.2. Immunoassay
10.3. Lateral Flow Assay
10.3.1. Competitive
10.3.2. Sandwich
10.4. Molecular Diagnostics
10.4.1. Isothermal Amplification
10.4.2. Pcr
11. Rapid Diagnostics Market, by Application
11.1. Introduction
11.2. Cardiac Markers
11.2.1. Creatine Kinase Mb
11.2.2. Myoglobin
11.2.3. Troponin
11.3. Diabetes
11.3.1. Type 1 Diabetes
11.3.2. Type 2 Diabetes
11.4. Infectious Diseases
11.4.1. Bacterial Infections
11.4.2. Parasitic Infections
11.4.3. Viral Infections
11.5. Oncology
12. Americas Rapid Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Rapid Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Rapid Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. Abbott Laboratories
15.3.3. Danaher Corporation
15.3.4. Siemens Healthineers AG
15.3.5. Becton, Dickinson and Company
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. bioMérieux SA
15.3.8. Hologic, Inc.
15.3.9. DiaSorin S.p.A.
15.3.10. Quidel Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. RAPID DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. RAPID DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY SANDWICH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CREATINE KINASE MB, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 68. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 71. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 74. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 75. CANADA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 127. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 132. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 135. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 136. GERMANY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 137. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 139. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 142. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 146. FRANCE RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 157. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 162. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 163. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 165. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 166. ITALY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 167. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 172. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 175. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 176. SPAIN RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 207. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 212. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 215. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 216. DENMARK RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 227. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 229. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 232. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 233. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 235. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 236. QATAR RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 237. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 239. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 242. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 245. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 246. FINLAND RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 267. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 272. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 275. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 276. EGYPT RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 277. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 282. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 283. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 285. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 286. TURKEY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 297. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 299. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 302. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 303. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 305. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 306. NORWAY RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 307. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 309. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 311. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 312. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 313. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 315. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 316. POLAND RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 338. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 340. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2030 (USD MILLION)
TABLE 343. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 344. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2030 (USD MILLION)
TABLE 346. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 347. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 348. INDIA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 349. INDIA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Rapid Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Hologic, Inc.
  • DiaSorin S.p.A.
  • Quidel Corporation

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 38.26 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.14 Billion
Compound Annual Growth Rate11.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Paper Diagnostics Market by Application, Platform, End User, Distribution Channel, Product Type, Material - Global Forecast to 2030 - Product Image

Paper Diagnostics Market by Application, Platform, End User, Distribution Channel, Product Type, Material - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Diagnostic Substances Market by Product Type, End-User, Application - Global Forecast to 2030 - Product Image

Diagnostic Substances Market by Product Type, End-User, Application - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR Based Diagnostics, Microarray Technology), By End-use (Hospitals & Clinics, Diagnostic & Reference Laboratories), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR Based Diagnostics, Microarray Technology), By End-use (Hospitals & Clinics, Diagnostic & Reference Laboratories), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 160 Pages
  • Global
From
Rapid Diagnostic Kits - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Rapid Diagnostic Kits - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.